HistAI CELLDX is now available worldwide!

HistAI has launched CELLDX*, a revolutionary cross-platform AI-powered slide viewer that transforms how pathologists and researchers analyze, collaborate, and automate routine tasks, now available worldwide for immediate deployment.

CELLDX represents a comprehensive solution that integrates advanced AI capabilities with intuitive slide viewing functionality, creating a unified platform for modern pathology workflows. This launch marks HistAI's transition from research-focused AI models to practical, deployment-ready clinical tools.

CELLDX Platform Features

AI-Powered Analysis: Integrated AI models for automated pathological analysis and pattern recognition
Cross-Platform Compatibility: Seamless operation across desktop, web, and mobile environments
Collaborative Tools: Real-time collaboration features for multi-user pathological review
Workflow Automation: Automated routine tasks including slide quality assessment and basic measurements
Universal Format Support: Compatible with all major whole slide image formats

The platform has been designed with input from practicing pathologists to ensure that it addresses real-world challenges in pathological diagnosis and research. CELLDX combines the precision of AI analysis with the expertise and judgment of human pathologists, creating a powerful hybrid approach to pathological assessment.

Key Capabilities

CELLDX offers a comprehensive suite of capabilities designed for modern pathology practice:

High-Performance Viewing: Smooth navigation and zoom functionality for gigapixel whole slide images
AI-Assisted Diagnosis: Real-time AI suggestions and annotations to support diagnostic decisions
Annotation Tools: Comprehensive annotation capabilities for research and educational purposes
Data Management: Secure storage and organization of pathological data with enterprise-grade security
Integration Ready: APIs and connectors for integration with existing laboratory information systems

The global availability of CELLDX addresses the growing need for digital pathology solutions that can scale across different healthcare systems and regulatory environments. The platform has been designed to meet various international standards for medical software and data security.

Impact on Pathology Practice

CELLDX is expected to significantly impact pathology practice by:

Reducing time required for routine pathological assessments
Improving consistency and accuracy in pathological diagnosis
Enabling remote consultation and telepathology workflows
Facilitating large-scale pathological research projects
Supporting pathology education and training programs

The launch of CELLDX represents a significant milestone in the democratization of AI-powered pathology tools. By making advanced AI capabilities accessible through an intuitive, user-friendly interface, HistAI is enabling pathologists worldwide to leverage cutting-edge technology without requiring deep technical expertise.

Early adopters of CELLDX have reported significant improvements in workflow efficiency and diagnostic confidence. The platform's ability to seamlessly integrate AI assistance with traditional pathological review has been particularly well-received by the pathology community.

*HistAI CELLDX is not for primary diagnosis. For Research Use only!